Stay updated on APL-2 Efficacy & Safety in PNH Patients Clinical Trial
Sign up to get notified when there's something new on the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page.

Latest updates to the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page
- Check3 days agoChange DetectedUpdated the page to revision v3.0.2 (replacing v3.0.1); removed the 'Back to Top' element, a minor UI change.SummaryDifference0.1%
- Check10 days agoChange DetectedThe page has updated the publication date of a study on Pegcetacoplan from July 28, 2025, to September 2025, reflecting the latest version of the research. Additionally, the revision number has been updated from v3.0.0 to v3.0.1.SummaryDifference0.3%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of detailed facility names and locations, as well as new research references related to paroxysmal nocturnal hemoglobinuria. Notably, the previous mentions of locations and terms have been removed, indicating a shift in focus or a reorganization of content.SummaryDifference11%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.6%
Stay in the know with updates to APL-2 Efficacy & Safety in PNH Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page.